Background: Inflammation and more specifically inflammatory cytokines are determinant in the development of microvascular diabetic complications, including neuropathy, retinopathy and nephropathy.
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Introduction:
Diabetes mellitus is one of the most frequent chronic diseases in childhood; patients with long standing diabetes may develop complication affecting the eyes, kidneys, nerves or major arteries. Approximately 30-40% of people with type one diabetes develop renal failure(1). Diabetic nephropathy is the single most common cause of end stage renal disease (ESRD) in the western countries (2). An increased urinary albumin excretion rate of 20 -200 mg/ 24 hours is called microalbuminuria (MU) can be detected and constitutes an early stage of nephropathy. Microalbuminuria was originally established as predictor of renal failure in patients with diabetes mellitus (3). Inflammation and more specifically inflammatory cytokines are determinant in the development of microvascular diabetic complications, including neuropathy, retinopathy and nephropathy (4). High sensitivity C-reactive protein (hs-CRP) production is part of the nonspecific acute-phase response to most forms of inflammation, infection and tissue damage. Hs-CRP is produced predominantly in hypatocytes as a pentamer of identical subunit in response to several cytokines such as Interleukin-6 (IL-6) (5). Hs-CRP has been shown to be increased in individuals with coronary artery disease. CRP directly binds highly atherogenic oxidized low-density lipoprotein cholesterol (LDL-C) and is present within lipid-laden plaques (6). Also hs-CRP is sensitive marker for diabetic nephropathy in type 1 diabetics (7) and recently, microalbuminuria has become a prognostic marker for cardiovascular disease (CVD) in diabetic patients and it is associated with an increased risk for all cause of cardiovascular mortality and cardiac abnormalities (8). So that, the aim of this study was to determine the relation between hs-CRP with microalbuminuria and considered as risk factors for cardiovascular disease among type 1 diabetic patient.
Materials and Methods
A total of 60 subjects were enrolled to National Diabetic Center (NDC) of Al-Mustansiriya University from October to December 2014. They were divided into two groups 30 patients with type 1 diabetes the mean age (16 ±0.31) years and 30 healthy subjects as a control group with mean age (17± 0.57) years. Patients with urinary tract infection, hypertension, renal failure and heart failure of any stage were excluded. A fasting blood sample was drawn from all subjects after an Relations of high sensitive C-reactive protein (hs-CRP) with microalbuminuria Abeer J. Hassan as a useful predictor of cardiovascular risk among type 1 diabetes mellitus patients Results in table (2) indicate the presence a highly significant positive correlation between HbA1c, microalbuminuria, AIP and hs-CRP in type 1 diabetic group. Also, a highly significant positive correlation between AIP and microalbuminuria level was noticed in patient group. 
Relations of high sensitive C-reactive protein (hs-CRP) with microalbuminuria Abeer J. Hassan as a useful predictor of cardiovascular risk among type 1 diabetes mellitus patients
a balance between the actual concentration of plasma triglyceride and low density lipoprotein (23). AIP correlates with size of pro-antiatherogenic lipoprotein particles (24). So that, AIP might be a better predictor of incidence of atherogenicity. The finding of the current study demonstrates a higher significant increase in microalbuminuria levels in T1DM group when compared with control group. Although, a statistical significant difference was detected in both urinary creatinine and urea in patients group when compared to that of control. These results are agreement with Razavi et al. whom concluded significant prevalence of microalbuminuria in children and adolescents with diabetes type 1 (25). Polyuria (excessive urine production) is a common symptom in T1DM patients and that causes damage to the glomerular membrane. An early indicator of glomerular dysfunction is the presence of microalbuminuria (26). Studies of patients with diabetes mellitus show that microalbuminuria precedes the nephropathy associated with diabetes particularly in T1DM. Progression from microalbuminuria to clinical nephropathy can be delayed with intensive therapy to normalize blood glucose and blood pressure (27) . Some authors suppose that poor glycemic control is the risk factor for proteinuria (28). Also, as the result the concentration of TG, VLDL-c, LDL-c and TC rises with increasing albumin excretion rate in patients with T1DM. Furthermore, recent work demonstrated that AIP correlates positively with microalbuminuria in T1DM patients group. So that, microalbuminuria could be considered risk factor for cardiovascular disease in type 1 diabetic (29). High sensitive-CRP an inflammatory factor with wide variability among various ages, sexes and ethnicities is modestly associated with CVD (30). CRP was previously reported as a predictor for micro-and macrovascular complications of diabetes (31). As expected, in present results serum hs-CRP levels in patients group were significantly higher than control group and that agree with others (32,33). The elevation in hs-CRP may be related to activation of macrophages and increased oxidative stress. So that, T1DM is now accepted to be a chronic immune-inflammatory disorder (34) and because of that hs-CRP suppose a marker for coronary artery disease (35).Also, a positive correlation was found between HbA1c, MU, AIP and hs-CRP.
Conclusion: this study suggests that hs-CRP can be used with MU as a biochemical marker to predict the early stage of cardiovascular disease in children and adolescents with type 1 diabetic mellitus.
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